<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Over the last five trading sessions, Moderna’s stock has cratered 30%, dropping from $350 a share all the way down to $240. The steep fall came after the Cambridge, Massachusetts-based company reported disappointing quarterly results that shocked Wall Street and revised down its forward guidance.
...read full article on InvestorPlace
